FDA OK of 1st ‘Biosimilar’ Drug May Mean Cheaper Options for Patients
Zarxio approval paves way for less expensive cutting-edge medications, experts sayContinue Reading
Zarxio approval paves way for less expensive cutting-edge medications, experts sayContinue Reading
U.S. adults with the skin condition spent over $29 billion in out-of-pocket health costs in 2012Continue Reading
Low sense of accomplishment, emotional exhaustion cited in surveyContinue Reading
But some question accuracy of estimateContinue Reading
Millions of consumers could lose health insurance subsidies in dispute over language in the lawContinue Reading
Researchers size up thousands to arrive at averagesContinue Reading
In study, scans show reduced circulation in brains of football players who had not recovered from the injuryContinue Reading
The gastrointestinal illness typically slows height, weight gains, experts sayContinue Reading
Study finds minors successfully purchased smoking devices 3 out of 4 times triedContinue Reading
But most believe it puts children at risk, study findsContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.